Commencing insulin therapy in patients with diabetes introduces a number of patient safety risks, including hypoglycaemia. Healthcare professionals commonly lack the expertise and time to educate each patient about titrating their changing dose requirements.
Diabetes is a widespread and growing condition, but insulin treatment is complex. The Regional Insulin Safety and Knowledge Project is working to reduce the risk of prescribing errors.
This safety report, from the National Patient Agency (NPSA), looks at the summary evidence for safe administration of insulin.